Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national blog main
4
×
national top stories
san diego blog main
san diego top stories
san francisco blog main
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
deals
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
new york blog main
new york top stories
president trump
raleigh-durham blog main
raleigh-durham top stories
san francisco top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
albert bourla
cancer
cancer immunotherapy
crispr therapeutics
drug prices
medicare
merck
novartis
pfizer
What
drug
4
×
today
4
×
roundup
acquisitions
advance
ahead
albert
ambien
american
annual
asco
attendees
attention
away
biggest
bio
biologic
biology
biotech
bourla
bringing
camp’s
cancer
cash
ceo
ceos
chicago
city
clinical
combinations
community’s
company
crispr
cytokine
days
dc
demonstrating
diego’s
drugs
enhanced
Language
unknown
Current search:
drug
×
today
×
" national blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Pharma CEOs to Senate: We Will Lower Drug Prices if Rebates Go Away
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More
@xconomy.com
5 years ago
Synthorx Raises $63M to Advance Suite of Enhanced Cytokine Drugs
